Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
7.92
+0.47 (6.31%)
Sep 9, 2025, 4:00 PM - Market closed
Curanex Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
219.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCURX News
- 11 days ago - U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall - Seeking Alpha
- 13 days ago - Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewsWire
- 14 days ago - Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering - GlobeNewsWire
- 11 months ago - Preclinical biopharma Curanex Pharmaceuticals files for a $10 million IPO - Renaissance Capital
- 11 months ago - Curanex Pharmaceuticals IPO Registration Document (S-1) - SEC